- CVS Caremark study: More education needed on genetic testing in prescribing antiplatelet drugs
- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- DEA pushes forward on rescheduling hydrocodone combination products
- Lupin launches generic Niaspan tablets
- Mallinckrodt receives FDA approval for Xartemis XR
BALTIMORE — Lupin Pharmaceuticals has launched a generic drug for cholesterol disorders, the company said.
Lupin announced the launch of fenofibrate tablets in the 48-mg and 145-mg strengths. The drug is used to treat hypercholesterolemia or mixed dyslipidemia and severe hypertriglyceridemia.
The drug is a generic version of Abbott's Tricor, which had sales of $1.26 billion during the 12-month period ended in June, according to IMS Health.